Results 171 to 180 of about 5,167 (211)
Some of the next articles are maybe not open access.
Climacteric, 2021
In premenopausal women, bone mineral density measurement by dual-energy X-ray absorptiometry should not be used as the sole guide for diagnosis or treatment of osteoporosis, universal screening with bone mineral density is not advised and the World Health Organization classification of bone status should not be applied.
M. Conradie, T. de Villiers
openaire +2 more sources
In premenopausal women, bone mineral density measurement by dual-energy X-ray absorptiometry should not be used as the sole guide for diagnosis or treatment of osteoporosis, universal screening with bone mineral density is not advised and the World Health Organization classification of bone status should not be applied.
M. Conradie, T. de Villiers
openaire +2 more sources
Premenopause-Dependent Changes
Gynecologic and Obstetric Investigation, 1996The authors retrospectively evaluated 1,773 climacteric outpatients in order to establish: (a) criteria able to distinguish different conditions in the transitional phase before menopause (advanced fertile age and premenopause) and (b) premenopause-related changes during the transition from one to the other of several clinical and laboratory parameters.
D, de Aloysio +4 more
openaire +2 more sources
Hereditary Premenopausal Breast Cancer
Oncology Research and Treatment, 2002Less than 1% of breast cancers occur between the age of 20 and 30 years, but more than 50% of breast cancers under the age of 30 years are hereditary. Breast cancer mainly occurs sporadically, however, in 5 to maximally 10% of cases a genetic predisposition is present.
E-S, Strobel, E, Fritschka
openaire +2 more sources
Osteoporosis in premenopausal women
Current Opinion in Rheumatology, 2017Purpose of review The scope of this review was to review the newest developments in the context of the existing knowledge on premenopausal bone fragility. Fragility fractures are common in postmenopausal women and men and diagnostic criteria for osteoporosis have been agreed and multiple pharmacological treatments have been ...
openaire +3 more sources
Osteoporosis Risk in Premenopausal Women
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2009Although clinically significant bone loss and fractures in healthy premenopausal women are rare, more women are seeking evaluation for osteoporosis from their health care providers. As pharmacists are in an ideal position to influence the management of premenopausal women with osteoporosis, it is important that pharmacists understand the available data
Sheryl F, Vondracek +2 more
openaire +2 more sources
Drugs, 2002
Modern treatment of premenopausal breast cancer is based on well-established prognostic and predictive factors for disease outcome such as nodal status, hormone receptor expression, tumour size, tumour grading and patient age. The development of strategies according to such individual risk profiles has resulted in significant improvements both in ...
Herbert G, Sayer +3 more
openaire +2 more sources
Modern treatment of premenopausal breast cancer is based on well-established prognostic and predictive factors for disease outcome such as nodal status, hormone receptor expression, tumour size, tumour grading and patient age. The development of strategies according to such individual risk profiles has resulted in significant improvements both in ...
Herbert G, Sayer +3 more
openaire +2 more sources
Premenopausal bone health assessment
Current Rheumatology Reports, 2005The World Health Organization criteria for classification of bone mineral density (BMD) cannot be applied to premenopausal women because the relationship between BMD and fracture risk is not the same as in postmenopausal women. Approximately 2.5% of premenopausal women have BMD that is more than 2.0 standard deviations below the mean BMD of an age ...
openaire +2 more sources
Ultrasound Assessment of Premenopausal Bleeding
Obstetrics and Gynecology Clinics of North America, 2008Vaginal bleeding is the most common cause of emergency care in the first trimester of pregnancy and accounts for the majority of premenopausal bleeding cases. Ultrasound evaluation combined with a quantitative beta human chorionic gonadotropin test is an established diagnostic tool to assess these patients.
Raj M, Paspulati +4 more
openaire +2 more sources

